Medexus Pharmaceuticals
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Medexus Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 47% to $113,054,000. The net income raised on -$214,000 and profit margin reached 0%. Total operating expenses were $48,720,000.

Profit Margin

Medexus Pharmaceuticals Inc. (TSX:MDP.TO): Profit margin
2012 0 -149.56K
2015 3.69M -3.21M -87.14%
2016 2.88M -1.77M -61.31%
2018 7.75M -2.69M -34.79%
2019 25.36M -4.88M -19.26%
2021 79.66M -28.26M -35.48%
2022 76.70M -2.87M -3.75%
2024 113.05M -214K -0.19%

MDP.TO Income Statement (2013 – 2023)

2023 2021 2020 2018 2017 2015 2014 2013
Revenue
Revenue
113.05M76.70M79.66M25.36M7.75M2.88M3.69M0
Cost of revenue
53.54M38.77M37.65M10.37M3.84M998.42K00
Gross profit
59.51M37.92M42.00M14.98M3.90M1.89M3.69M0
Operating exp.
Research and development
8.03M5.87M4.59M000542.62K0
Selling and marketing
10.58M9.51M16.89M9.97M4.50M2.47M3.15M0
Total operating expenses
48.72M50.30M41.27M15.66M6.09M5.28M4.90M149.56K
Operating income
10.79M-14.99M-1.37M-4.39M-2.17M-1.03M-1.21M-149.56K
Other income (expenses), net
-10.68M20.77M-30.12M-1.29M-501.00K-431.64K38.82K0
Income before tax
106K-3.82M-31.50M-4.71M-2.69M-1.77M-3.21M-149.56K
Income tax expense
320K-941K-3.23M166.28K918.89K732.52K269.44K0
Net income
-214K-2.87M-28.26M-4.88M-2.69M-1.77M-3.21M-149.56K
Earnings per share
Basic EPS
-0.00-0.15-1.86-0.49-0.47-0.37-0.67-0.27
Diluted EPS
-0.00-0.14-1.86-0.49-0.47-0.37-0.67-0.27
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source